Papavramidis Theodosios S, Stavrou George, Papakostas Pyrros, Grosomanidis Vasilis, Kokkota Smaro, Michalopoulos Antonios, Kolios George, Kotzampassi Katerina
Department of Surgery, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Obes Surg. 2018 Aug;28(8):2374-2378. doi: 10.1007/s11695-018-3168-1.
The BioEnterics Intragastric Balloon [BIB] is a reliable, non-invasive technique to manage obesity for subjects who refuse or are unsuitable for bariatric surgery. In a prior study, BIB placed in the antrum [A] was found to have significantly better results on weight loss in relation to that in fundus [F], but many balloons initially placed in the F were eventually found in the A. The aim of the present analysis was to evaluate whether the balloon position [firmly in F, firmly in A, or transient from F to A [FA]] influences the 3- and 6-month weight loss.
Six hundred sixty-eight patients that underwent successful BIB treatment were assigned into three groups: group F [n = 354], group A [n = 159], and group AF [n = 155]. Weight loss parameters were recorded and analyzed at 3 and 6 months.
In all three groups, there was a significant, progressive reduction of BMI at 3 and 6 months. At 6 months, BMI reduction between groups F and A, and F and FA [p = 0.001] and groups A and FA [p = 0.018] was prominent.
The position of the BIB affects its effectiveness: better results when antrum is involved. This observation seems to give a great perspective to newly established gastric space-occupying devices, which aim to have a compartment constantly present in the antrum. However, further studies have to be performed in order to validate the results and more importantly to clarify the mechanisms implied.
BioEnterics胃内球囊(BIB)是一种可靠的非侵入性技术,用于治疗拒绝或不适合进行减肥手术的肥胖患者。在之前的一项研究中,发现置于胃窦(A)的BIB在减肥方面的效果明显优于置于胃底(F)的BIB,但许多最初置于F的球囊最终却出现在A。本分析的目的是评估球囊位置(牢固位于F、牢固位于A或从F短暂移至A [FA])是否会影响3个月和6个月的体重减轻情况。
668例接受BIB治疗成功的患者被分为三组:F组(n = 354)、A组(n = 159)和AF组(n = 155)。在3个月和6个月时记录并分析体重减轻参数。
在所有三组中,3个月和6个月时BMI均有显著的逐步下降。在6个月时,F组与A组、F组与FA组(p = 0.001)以及A组与FA组(p = 0.018)之间的BMI下降差异显著。
BIB的位置会影响其效果:涉及胃窦时效果更佳。这一观察结果似乎为新研发的胃占位装置提供了广阔前景,这些装置旨在使胃窦中始终存在一个腔室。然而,必须进行进一步研究以验证结果,更重要的是阐明其中涉及的机制。